The executive protection firm insurance market is forecasted to grow to $3.05 billion by 2029, driven by rising security threats, increasing high-net-worth individuals, and expanding corporate travel risks. North America leads market share while Asia-Pacific shows fastest growth.
House Republicans plan to block ACA subsidy extensions, risking higher premiums for millions and impacting U.S. health insurance market stability. Insights on policy and regulatory implications.
The expiration of Affordable Care Act subsidies in 2026 will lead to higher premiums and reduced coverage, impacting U.S. families and insurance market dynamics.
The U.S. Senate's failure to extend Affordable Care Act subsidies raises concerns over rising health insurance premiums for ACA marketplace enrollees in 2026. Legislative deadlock and debates over healthcare reform impact market stability and coverage affordability.
ACA subsidy expiration in 2026 drives large premium hikes, impacting families and insurance market stability. Learn key insights for insurance professionals.
The U.S. Senate rejects ACA subsidy extensions, triggering significant health insurance premium hikes nationwide, with Wyoming seeing the steepest increase. Explore the market and policy impacts.
Enhanced ACA premium tax credits expire at end of 2025, causing significant 2026 health insurance premium increases and enrollment challenges for millions of Americans.
Keefe, Bruyette & Woods announces the Q4 2025 rebalance of several Nasdaq financial sector indexes impacting insurance, banking, fintech, and REIT ETFs effective December 22.
A new report details the consequences of Medicaid and ACA funding cuts, revealing rising premiums, hospital closures, and workforce reductions across the U.S. health care system. Legislative decisions on ACA tax credits could affect millions of Americans' health coverage.
Explore critical U.S. health insurance and public health issues shaping market dynamics in 2025, including ACA premium hikes, pharmacist shortages, nurse union growth, and vaccine policy challenges.
